Carol Green
Senior Director, Preclinical Development
Carol Green, Ph.D., DABT, is an accomplished scientist with expertise in toxicology, absorption, distribution, metabolism, and excretion studies. In her current role, she is the principal investigator for four National Institutes of Health contracts and one research grant.
Her research includes developing new in vitro human tissue models to predict toxicity of pharmaceuticals and environmental chemicals, and advancing the preclinical development of promising pharmaceutical candidates against chemical threat agents. She also provides preclinical pharmacology and toxicology data on anti-infective agents, cancer chemopreventive and therapeutic agents, and other pharmaceuticals. Green oversees the development of data included in Investigational New Drug applications and has served on project teams for more than 10 drugs that have moved into Phase I trials.
Green has authored or co-authored 57 published papers and 98 abstracts. She is a diplomate for the American Board of Toxicology, and past president of the Genetic and Environmental Toxicology Association of Northern California. She received a Ph.D. in pharmacology and toxicology from the University of California, Davis, and conducted postdoctoral work in biochemical toxicology at SRI.
Recent publications
-
A tandem liquid chromatography and tandem mass spectrometry (LC/LC–MS/MS) technique to separate and quantify steroid isomers 11β-methyl-19-nortestosterone and testosterone
Here we describe a high-sensitivity LC/LC-MS/MS method that combines chiral chromatography and reverse-phase chromatography.
-
Pharmacokinetics and Safety Studies in Rodent Models Support Development of EPICERTIN as a Novel Topical Wound-Healing Biologic for Ulcerative Colitis
This study established for the first time the pharmacokinetics, bioavailability, and acute safety of EPICERTIN in healthy and dextran sodium sulfate-induced colitic mice and healthy rats.
-
Enhancement of sensitivity and quantification quality in the LC-MS/MS measurement of large biomolecules with sum of MRM (SMRM)
We describe here an approach to boost detection sensitivity and expand dynamic range in the quantitation of large molecules while maintaining analytical specificity using summation of MRM (SMRM) transitions and…
-
Formulation Approaches to Improving the Delivery of an Antiviral Drug with Activity against Seasonal Flu
The main objective of the present study was to develop formulations of noscapine hydrochloride hydrate with enhanced solubility and bioavailability using co-solvent- and cyclodextrin-based approaches.
-
Pharmacokinetics and Metabolism of 4R-Cembranoid
The purpose of this study was to examine the metabolism and pharmacokinetics of 4R as part of its preclinical development as a neuroprotective drug.
-
Nitrocobinamide, a New Cyanide Antidote That Can Be Administered by Intramuscular Injection
Here we show that adding sodium nitrite to cobinamide yields a stable derivative that rescues cyanide-poisoned mice and rabbits when given by intramuscular injection.